Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Br J Dermatol ; 183(4): 673-683, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32128788

RESUMO

BACKGROUND: Psychological stress is commonly cited as a risk factor for melanoma, but clinical evidence is limited. OBJECTIVES: This study aimed to evaluate the association between partner bereavement and (i) first-time melanoma diagnosis and (ii) mortality in patients with melanoma. METHODS: We conducted two cohort studies using data from the U.K. Clinical Practice Research Datalink (1997-2017) and Danish nationwide registries (1997-2016). In study 1, we compared the risk of first melanoma diagnosis in bereaved vs. matched nonbereaved people using stratified Cox regression. In study 2 we estimated hazard ratios (HRs) for death from melanoma in bereaved compared with nonbereaved individuals with melanoma using Cox regression. We estimated HRs separately for the U.K. and for Denmark, and then pooled the data to perform a random-effects meta-analysis. RESULTS: In study 1, the pooled adjusted HR for the association between partner bereavement and melanoma diagnosis was 0·88 [95% confidence interval (CI) 0·84-0·92] across the entire follow-up period. In study 2, we observed increased melanoma-specific mortality in people experiencing partner bereavement across the entire follow-up period (HR 1·17, 95% CI 1·06-1·30), with the peak occurring during the first year of follow-up (HR 1·31, 95% CI 1·07-1·60). CONCLUSIONS: We found decreased risk of melanoma diagnosis, but increased mortality associated with partner bereavement. These findings may be partly explained by delayed detection resulting from the loss of a partner who could notice skin changes. Stress may play a role in melanoma progression. Our findings indicate the need for a low threshold for skin examination in individuals whose partners have died. What is already known about this topic? Psychological stress has been proposed as a risk factor for the development and progression of cancer, including melanoma, but evidence is conflicting. Clinical evidence is limited by small sample sizes, potential recall bias associated with self-report, and heterogeneous stress definitions. What does this study add? We found a decreased risk of melanoma diagnosis, but increased mortality associated with partner bereavement. While stress might play a role in the progression of melanoma, an alternative explanation is that bereaved people no longer have a close person to help notice skin changes, leading to delayed melanoma detection. Linked Comment: Talaganis et al. Br J Dermatol 2020; 183:607-608.


Assuntos
Luto , Melanoma , Estudos de Coortes , Dinamarca/epidemiologia , Humanos , Sistema de Registros , Fatores de Risco , Estresse Psicológico/epidemiologia
2.
Alcohol ; 14(4): 333-43, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9209548

RESUMO

Circulating horseradish peroxidase (HRP) was used as a tracer to determine if the blood-brain barrier to protein was altered by dietary prenatal alcohol exposure. Animals were prepared for light microscopic visualization of HRP after HRP infusion on gestational days 16, 18, 20, 22 and postnatal day 4. There was no consistent evidence of HRP leakage through the BBB in the alcohol-exposed animals compared to control animals. Capillary endothelial cells and perivascular astrocytic endfeet were morphologically characterized by electron microscopy in rat optic nerve and cerebellum following dietary prenatal and postnatal ethanol exposure. Photomontages of optic nerve capillaries from G20 and P5 animals and cerebellar capillaries from P15 animals were examined for evidences of effects of alcohol on the development of the capillaries and adjacent astroglial endfeet. There was no consistent evidence of any alcohol-induced effect that could indicate a disruption of the vessel, the endothelial tight junctions, the perivascular glial limiting membranes, or the extent of vascular ensheathment by astrocytic endfeet.


Assuntos
Barreira Hematoencefálica/efeitos dos fármacos , Barreira Hematoencefálica/fisiologia , Encéfalo/crescimento & desenvolvimento , Depressores do Sistema Nervoso Central/farmacologia , Etanol/farmacologia , Efeitos Tardios da Exposição Pré-Natal , Animais , Astrócitos/efeitos dos fármacos , Astrócitos/ultraestrutura , Peso Corporal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/ultraestrutura , Capilares/efeitos dos fármacos , Capilares/ultraestrutura , Cerebelo/efeitos dos fármacos , Cerebelo/crescimento & desenvolvimento , Cerebelo/ultraestrutura , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/ultraestrutura , Feminino , Histocitoquímica , Peroxidase do Rábano Silvestre , Masculino , Microscopia Eletrônica , Nervo Óptico/efeitos dos fármacos , Nervo Óptico/crescimento & desenvolvimento , Nervo Óptico/ultraestrutura , Tamanho do Órgão/efeitos dos fármacos , Gravidez , Ratos
3.
Clin Lab Med ; 15(1): 85-108, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7781280

RESUMO

The search for clinical outcomes associated with antiphospholipid antibodies (aPL) has been ongoing for a decade. This article focuses on the clinical use of tests for the detection of aPL. A review of the current thinking regarding the pathophysiology of antiphospholipid syndromes is relevant to the discussion of different aPL assays and methodologies. The value of aPL testing in specified patient populations is analyzed.


Assuntos
Síndrome Antifosfolipídica/diagnóstico , Humanos , Técnicas Imunológicas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA